Read-Gene S.A. (WSE: RDG)
Health Care · Biotechnology · PL
zł4.96
-1.59% today · -19.7% 1Y
Read-Gene S.A. (WSE: RDG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $15.06M.
Over the last twelve months the share price has lost 19.7%, trading between 4.57 and 6.20.
Tweenvest scores Read-Gene S.A. across four factors: quality 59/100, value 59/100, growth 100/100. Its strongest factor is growth.
RDG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.06M
- Revenue (TTM)
- $4.43M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.21
- 52-week high
- zł6.20
- 52-week low
- zł4.57
- Avg volume (3M)
- —
- Shares outstanding
- 11.79M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Psyence Biomedical Ltd.NasdaqCM: PBM | $16.10M | $4.22 | -15.09% |
| TScan Therapeutics, Inc.NasdaqGM: TCRX | $15.66M | $0.23 | -2.94% |
| Onco-Innovations LimitedCNSX: ONCO | $15.60M | CA$0.32 | -13.51% |
| Xcell Therapeutics Inc.KOSDAQ: A373110 | $15.16M | ₩1,169.00 | +9.87% |
| Dyadic International, Inc.NasdaqCM: DYAI | $14.98M | $0.41 | -7.43% |
| SenzaGen ABOM: SENZA | $14.97M | Skr4.56 | +1.10% |
| Valbiotis SAENXTPA: ALVAL | $14.70M | €0.56 | +0.36% |
| Poongjeon Pharmacy CO.,LTD.KOSDAQ: A298060 | $14.56M | ₩2,195.00 | -5.39% |
Figures last refreshed Oct 18, 2026.